SpaceX Successfully Launches Massive Starship V3 Marking Milestone in Space Transportation Portugals Meo Takes Legal Action Against State Over Huawei 5G Ban Seeks 82 Million in Damages US Stock Futures and Bond Yields Fall on Reports Putin Updated Nuclear Doctrine Markets Record Run Boosts Portfolio Top and Bottom Performers Over Six Weeks US Military Strikes in Iran Raise Geopolitical Tensions Oil Markets on Edge Quantinuum Sets IPO Terms Targeting Nearly 13 Billion Valuation in Quantum Computing Debut MGY Q1 2026 Earnings EPS Beats Expectations as Operational Efficiency Drives Surprise DJCO Q4 2025 Earnings Strong EPS Beat Amid Sparse Disclosure ONL Q1 2026 Earnings Significant EPS Miss as Losses Widen XCF Global Inc SAFX Q1 2026 Earnings Narrow EPS Beat Sparks Cautious Optimism MBC Q1 2026 Earnings Profit Beat Defies Expectations Amid Cost Discipline DJCO Q4 2025 Earnings Strong EPS Beat Amid Sparse Disclosure Silexion Therapeutics SLXN Slips 3 as Stock Approaches Key Support at 040 Bgin Blockchain BGIN Tests Support Zone Following Modest Decline Ball Corporation BALL Edges Higher as Packaging Sector Shows Stability Brookfield Infrastructure Corporation 7250 Subordinated Notes due 2084 BIPJ Modest Dip Amid Steady Income Appeal RiverNorth Opportunistic Municipal Income Fund RMI Edges Higher on Modest Gains XP Inc Files Form 6K With SEC as Part of Ongoing Regulatory Disclosure Interlink Electronics Q3 2025 Earnings Narrowed Loss Beats Expectations Amid Opaque Revenue Picture Enliven Therapeutics ELVN Faces Pressure as Shares Dip 168 Key Support Levels in Focus Baytex Energy Q1 2026 Earnings Significant Miss as EPS Turns Negative Samsara IOT Q1 2026 Earnings Strong Operating Leverage Drives EPS Beat PPBT Q1 2025 Earnings Narrowing Losses and Pipeline Progress Drive Optimism DSGR Q1 2026 Earnings EPS Surpasses Estimates Stock Reacts Positively ONCY Q3 2025 Earnings Clinical Progress Overshadows WiderThanExpected Loss Eagle Point Credit Company Inc ECC Q1 2026 Earnings EPS Misses Estimates as Net Investment Income Declines Prelude Therapeutics Q1 2026 Earnings Significant EPS Beat Amid No Revenue